Scientific journal
Fundamental research
ISSN 1812-7339
"Перечень" ВАК
ИФ РИНЦ = 1,674

THE SYSTEM OF IL-6 AS A RISK FACTOR OF URGENT CRITICAL CONDITION DEVELOPMENT IN PATIENTS WITH ESSENTIAL HYPERTENSION

Radaeva O.A. 1 Novikova L.V. 2
1 Mordovian State N.P. Ogariov University
2 Mordovian State N.P. Ogariov University, Saransk
Objectives. We tested the hypothesis that serum interleukin-6 (IL-6) and its soluble receptor (sIL-6R) levels predict cardiovascular events in patients with in essential hypertension (ЕAН). Methods. We prospectively studied in 120 patients with II stage ЕAН (68 men and 52 women), 49,5 ± 2,8 years of age. Serum IL-6 and sIL-6R levels were measured with an enzyme-linked immunosorbent assay. Results. During a median 5-year follow-up, 32 cardiovascular events occurred. Both total IL-6 and sIL-6R levels were direct associated with the risk of cardiovascular events. Patients in the 2 higher quartiles of IL-6 (≥ 18,2 pg/ml) had an increase risk of cardiovascular events compared with patients in the 2 lower quartiles (relative risk: 7,95 % confidence interval: 2,6 to 13,3). Patients in the 2 higher quartiles of IL-6 (≥ 18,2 pg/ml) had an increase risk of cardiovascular events compared with patients in the 2 lower quartiles (relative risk: 7,95 % confidence interval 2,6 to 13,3). Compared with the third quartile of serum sIL-6R levels (1739–1890 pg/ml), the relative risks the first-ever stroke and the myocardial infarction for patients with II stage ЕAН were as follows fourth quartile (1891 – 2218 pg /ml), 6 (95 % confidence interval, 2,7–10). Conclusions. High serum interleukin-6 (IL-6) and its soluble receptor (sIL-6R) predicted a increased 5-year risk of cardiovascular events in patients with ЕAН.
essential hypertension
interleukin-6
soluble receptor
myocardial infarction
blood stroke
1. Gusev E.Ju., Jurchenko L.N., Chereshnev V.A., Zotova N.V. Citokiny i vospalenie (Cytokines & inflammation), 2008, no. 1, pp. 15–23.
2. Chazova I.E., Ratova L.G., Bojcov S.A., Nebieridze D.V., Sistemnye gipertenzii [System Hypertension], 2010, no. 3, pp. 5–34.
3. Lang T.A., Sesik M. Kak opisyvat’ statistiku v medicine [How To Report Statistics in Medecine], Moscow, 2011, 480 p.
4. Radaeva O.A., Novikova L.V. Vestnik Rossijskogo universiteta druzhby narodov [Vestnik Peoples Friendship University of Russia], 2007, no. 6, pp. 195–198.
5. Rossijskij statisticheskij ezhegodnik. 2011: Stat.sb. Rosstat. – Moscow, 2011, 795 p.
6. Safronenko A.V., Makljakov Ju.S., Harseeva G.G. Fundamental’nye issledovanija [Fundamental researches], 2012, no. 2, pp. 124–127.
7. Shvarc V. Citokiny i vospalenie [Cytokines & inflammation], 2009, no. 3, pp. 3–10.
8. Ridker P.M., Buring J.E., Rifai N., Cook N. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score, JAMA. 2007. Vol.297. no. 6. рр. 611–619.
9. Troncale S. Modeling and Simulation with Hybrid Functional Petri Nets of the Role of Interleukin-6 in Human Early Haematopoiesis / S. Troncale, F. Tahi, D. Campard, Jean-Pierre Vannier, J. Guespin 2006. Proceedings of the Pacific Symposium, Maui, Hawaii, USA, 3–7 January 2006. World Scientific 2006. no. 11. рр. 427–438.
10. Ohlsson C. High Serum Testosterone Is Associated With Reduced Risk of Cardiovascular Events in Elderly Men / E. Barrett-Connor, S. Bhasin // Journal of the American College of Cardiology. 2011. no. 58(16). рр. 1674–1681.
11. Zhang Q. , Ding Н., Yan J., Wang W., Ma A., Zhu Z., Cianflone K., Hu F.B.Plasma tissue kallikrein level is negatively associated with incident and recurrent stroke: a multicenter case-control study in China, Ann Neurol. 2011. no. 70 (2). рр. 265–273.

Рецензенты:

Потатуркина-Нестерова Н.И., д.м.н., профессор, зав. курсом микробиологии кафедры общей и клинической фармакологии, ФВПОУ ВПО «Ульяновский государственный университет», г. Ульяновск;

Карзакова Л.М., д.м.н., профессор, заведующая кафедрой госпитальной терапии № 2 медицинского факультета, ФВПОУ ВПО «Чувашский государственный университет имени И.Н. Ульянова», г. Чебоксары.